These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 26981782)

  • 1. Synthesis and Structure-Activity Relationships of N-Dihydrocoptisine-8-ylidene Aromatic Amines and N-Dihydrocoptisine-8-ylidene Aliphatic Amides as Antiulcerative Colitis Agents Targeting XBP1.
    Xie M; Zhang HJ; Deng AJ; Wu LQ; Zhang ZH; Li ZH; Wang WJ; Qin HL
    J Nat Prod; 2016 Apr; 79(4):775-83. PubMed ID: 26981782
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and Structure-Activity Relationships of Quaternary Coptisine Derivatives as Potential Anti-ulcerative Colitis Agents.
    Zhang ZH; Zhang HJ; Deng AJ; Wang B; Li ZH; Liu Y; Wu LQ; Wang WJ; Qin HL
    J Med Chem; 2015 Sep; 58(18):7557-71. PubMed ID: 26321079
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Versatile methods for synthesizing organic acid salts of quaternary berberine-type alkaloids as anti-ulcerative colitis agents.
    Zhang ZH; Li J; Zhang HJ; Deng AJ; Wu LQ; Li ZH; Song HR; Wang WJ; Qin HL
    J Asian Nat Prod Res; 2016 Jun; 18(6):576-86. PubMed ID: 27097666
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Syntheses and structure-activity relationships on antibacterial and anti-ulcerative colitis properties of quaternary 13-substituted palmatines and 8-oxo-13-substituted dihydropalmatines.
    Song L; Zhang HJ; Deng AJ; Li J; Li X; Li ZH; Zhang ZH; Wu LQ; Wang SQ; Qin HL
    Bioorg Med Chem; 2018 May; 26(9):2586-2598. PubMed ID: 29680749
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Trifluoromethylation of dihydrocoptisines and the effect on structural stability and XBP1-activating activity.
    Li X; Zhang HJ; Li ZH; Wu LQ; Deng AJ; Qin HL
    J Asian Nat Prod Res; 2022 Apr; 24(4):388-396. PubMed ID: 34132154
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cembranoids from the Gum Resin of Boswellia carterii as Potential Antiulcerative Colitis Agents.
    Ren J; Wang YG; Wang AG; Wu LQ; Zhang HJ; Wang WJ; Su YL; Qin HL
    J Nat Prod; 2015 Oct; 78(10):2322-31. PubMed ID: 26457560
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New synthetic method of 8-oxocoptisine starting from natural quaternary coptisine as anti-ulcerative colitis agent.
    Zhang ZH; Wu LQ; Deng AJ; Yu JQ; Li ZH; Zhang HJ; Wang WJ; Qin HL
    J Asian Nat Prod Res; 2014; 16(8):841-6. PubMed ID: 25027365
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel, potent small-molecule inhibitors of the molecular chaperone Hsp90 discovered through structure-based design.
    Dymock BW; Barril X; Brough PA; Cansfield JE; Massey A; McDonald E; Hubbard RE; Surgenor A; Roughley SD; Webb P; Workman P; Wright L; Drysdale MJ
    J Med Chem; 2005 Jun; 48(13):4212-5. PubMed ID: 15974572
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The discovery of potent agonists for GPR88, an orphan GPCR, for the potential treatment of CNS disorders.
    Bi Y; Dzierba CD; Fink C; Garcia Y; Green M; Han J; Kwon S; Kumi G; Liang Z; Liu Y; Qiao Y; Zhang Y; Zipp G; Burford N; Ferrante M; Bertekap R; Lewis M; Cacace A; Westphal RS; Kimball D; Bronson JJ; Macor JE
    Bioorg Med Chem Lett; 2015 Apr; 25(7):1443-7. PubMed ID: 25754495
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design, synthesis and in vitro evaluation of novel uni- and bivalent ligands for the cannabinoid receptor type 1 with variation of spacer length and structure.
    Huang G; Pemp D; Stadtmüller P; Nimczick M; Heilmann J; Decker M
    Bioorg Med Chem Lett; 2014 Sep; 24(17):4209-14. PubMed ID: 25096297
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alkyl-substituted amino acid amides and analogous di- and triamines: new non-peptide G protein activators.
    Leschke C; Storm R; Breitweg-Lehmann E; Exner T; Nürnberg B; Schunack W
    J Med Chem; 1997 Sep; 40(19):3130-9. PubMed ID: 9301677
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 13,14-dihydrocoptisine--the genuine alkaloid from Chelidonium majus.
    Paulsen J; Yahyazadeh M; Hänsel S; Kleinwächter M; Ibrom K; Selmar D
    Phytochemistry; 2015 Mar; 111():149-53. PubMed ID: 25666130
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discovery of S-adenosyl-L-homocysteine hydrolase inhibitors based on non-adenosine analogs.
    Nakao A; Suzuki H; Ueno H; Iwasaki H; Setsuta T
    Bioorg Med Chem Lett; 2014 Sep; 24(17):4336-40. PubMed ID: 25022879
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Synthesis and pharmacological properties of some alpha-phenylalkylamides and alpha-phenylalkylamines (author's transl)].
    Costakis E; Tsatsas G
    Ann Pharm Fr; 1978; 36(7-8):349-60. PubMed ID: 742812
    [No Abstract]   [Full Text] [Related]  

  • 15. Synthesis and antimycobacterial properties of N-substituted 6-amino-5-cyanopyrazine-2-carboxamides.
    Zitko J; Dolezal M; Svobodova M; Vejsova M; Kunes J; Kucera R; Jilek P
    Bioorg Med Chem; 2011 Feb; 19(4):1471-6. PubMed ID: 21273083
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and biological evaluation of novel bis-aromatic amides as novel PTP1B inhibitors.
    Wang WL; Huang C; Gao LX; Tang CL; Wang JQ; Wu MC; Sheng L; Chen HJ; Nan FJ; Li JY; Li J; Feng B
    Bioorg Med Chem Lett; 2014 Apr; 24(8):1889-94. PubMed ID: 24684845
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design, synthesis and structure-activity relationships of (1H-pyridin-4-ylidene)amines as potential antimalarials.
    Rodrigues T; Guedes RC; dos Santos DJ; Carrasco M; Gut J; Rosenthal PJ; Moreira R; Lopes F
    Bioorg Med Chem Lett; 2009 Jul; 19(13):3476-80. PubMed ID: 19467600
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design, synthesis, and structure-activity relationship of indole-3-glyoxylamide libraries possessing highly potent activity in a cell line model of prion disease.
    Thompson MJ; Borsenberger V; Louth JC; Judd KE; Chen B
    J Med Chem; 2009 Dec; 52(23):7503-11. PubMed ID: 19842664
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 4-Aryl-4-oxo-N-phenyl-2-aminylbutyramides as acetyl- and butyrylcholinesterase inhibitors. Preparation, anticholinesterase activity, docking study, and 3D structure-activity relationship based on molecular interaction fields.
    Vitorović-Todorović MD; Juranić IO; Mandić LM; Drakulić BJ
    Bioorg Med Chem; 2010 Feb; 18(3):1181-93. PubMed ID: 20061157
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ultimate carcinogenic metabolites from aromatic and heterocyclic aromatic amines: a computational study in relation to their mutagenic potency.
    Borosky GL
    Chem Res Toxicol; 2007 Feb; 20(2):171-80. PubMed ID: 17261035
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.